Name: 글로벌 시장 동향
SKU: MD4254
Availability: InStock

보고서 요약(국문)

세계 바이오의약품 튜빙 시장 규모는 2022년 35억 8,040만 달러에 달했으며, 2030년까지 66억 7,420만 달러에 이르는 높은 성장세를 보일 것으로 예상됩니다. 바이오의약품 튜빙 시장은 2023년부터 2030년까지 연평균 8.3%의 성장률을 기록할 것으로 전망됩니다. 바이오의약품 튜빙은 의료 및 바이오의약품 분야의 핵심적인 요구를 충족하는 데 사용됩니다. 압출 성형 방식으로 생산되는 바이오의약품 튜빙은 연동 펌프, 영양 튜브, 약물 투여 시스템 등에 널리 사용됩니다. 마취 및 호흡기 장비, 정맥 주사, 바이오의약품 실험실 장비 등 다양한 분야에서 사용되는 실리콘 튜빙의 뛰어난 열적, 기계적, 화학적 특성과 같은 장점들이 시장 성장에 기여할 것으로 예상됩니다.
바이오의약품 튜빙 시장 동향 및 추세
일회용 시스템(SUS)의 적용 확대가 시장 성장을 견인하고 있습니다.
일회용 시스템(SUS)의 적용이 증가함에 따라 전 세계 바이오의약품 튜빙 시장 규모가 확대되고 있습니다. SUS는 뛰어난 신뢰성, 비용 효율성, 그리고 전반적인 시스템 내구성을 바탕으로 바이오의약품 기업들의 상류 및 하류 공정에 널리 사용되고 있습니다. SUS 구성 요소는 유연한 바이오의약품 튜빙을 사용하여 공정 이송 라인 및 기타 장비에 무균 연결부를 통합하는 방식으로 구성됩니다.
전 세계 바이오의약품 제조업체들은 수율 향상, 비용 절감, 그리고 제품 출시 기간 단축에 기여하는 신뢰할 수 있는 일회용 무균 커넥터, 무균 분리 장치, 그리고 개방형 제품을 위해 바이오의약품 튜빙을 활용하고 있습니다. 일회용 커넥터는 스케일업, 샘플링, 크로마토그래피, 여과, 최종 충전 등 다양한 공정에서 제조 설비를 상류 및 하류 공정에 통합하는 데 사용됩니다.

정부 지원금 증가와 실리콘 튜빙이 제공하는 이점은 제조업체에 수익성 높은 성장 기회를 창출합니다.
정부와 산업계는 바이오 제약 산업에서 일회용 시스템(SUS)이 급증함에 따라 튜빙 및 기타 구성 요소의 재질 무결성 및 순도에 대한 보편적인 표준화를 개발하기 위해 많은 노력을 기울여 왔습니다.
실리콘 튜빙은 멸균 절차를 견딜 수 있고, 추출 가능 물질 테스트에서 양성 결과를 보이며, 동물 유래 물질이 없다는 장점이 있습니다. 이러한 산업 분야는 성능, 유연성 및 비용 측면에서 여러 응용 분야에 공통적인 튜빙 요구 사항을 가지고 있습니다.
연동 펌프 또는 실리콘 튜빙은 제약 회사의 제조 공정에서 자주 사용됩니다. 용접 및 밀봉이 가능하여 여러 재료를 생략할 수 있는 고순도, 유연성, 연동 펌프 튜빙 사양은 TPE와 같은 튜빙 재료로 충족됩니다. 실리콘과 같은 특정 TPE는 Y자형 및 T자형 연결부로 성형할 수 있어 피팅 필요성을 더욱 줄이고 누출 위험을 낮춥니다.

바이오의약품 튜빙의 사이클로실록산 오염물질, 시장 성장 저해 요인으로 작용
제약 회사들은 가공 장비에서 발생하는 오염 가능성에 대해 점점 더 우려하고 있습니다. 미국 식품의약국(FDA)은 지난 6개월간 의약품 리콜의 15%가 가공 장비 오염 때문이라고 밝혔는데, 이는 문제의 심각성을 보여줍니다.
주요 우려 사항은 일회용 부품을 구성하는 플라스틱 가공 재료가 의약품과 직접 접촉하는 것입니다. 이러한 접촉은 최종 의약품의 효능, 안전성 또는 품질에 영향을 미칠 수 있는 물질의 존재로 이어질 수 있다는 점은 잘 알려져 있습니다. 수백만 달러 규모의 약리학 연구 및 치료에 참여하는 제조업체에게 제품 개발이나 브랜드 이미지에 미치는 영향은 상당합니다.
바이오의약품 튜빙 시장 세분화 분석
글로벌 바이오의약품 튜빙 시장은 유형, 적용 분야 및 지역별로 세분화됩니다.

수요 증가로 인해 실리콘 바이오의약품 튜빙 부문은 바이오의약품 튜빙 시장 점유율의 53.8%를 차지할 것으로 예상됩니다.
백금 촉매 실리콘 튜빙은 고유의 순도, 유연성 및 손쉬운 멸균으로 인해 여러 이점이 있습니다. 또한 실리콘 소재는 불활성이며 생체 적합성이 뛰어나 부작용이 없습니다. 실리콘 튜빙은 견고성, 꼬임 방지 및 내압성으로 인해 제약 및 바이오의약품 산업에서 공정 처리에 적합한 옵션입니다.
실리콘이라는 열경화성 고분자는 -80°C에서 215°C까지의 온도를 견딜 수 있습니다. 이 실리콘은 USP 88 Class VI 테스트를 통과했으며 감작성, 발열성, 세포 독성, 유전 독성 또는 용혈성이 없습니다.
예를 들어, W. L. Gore and Associates, Inc.의 GORE STA-PURE 펌프 튜빙 시리즈 PCS는 실리콘 튜빙의 한계를 극복하는 탁월한 특허받은 하이브리드 설계를 사용합니다. 최대 100 PSIG의 압력에서도 PCS 시리즈 튜빙은 균일한 유량을 제공합니다. PCS 시리즈는 높은 유연성, 내구성, 탄성을 갖춘 표준 사이즈로 제공되며 CIP/SIP 및 오토클레이브 멸균이 가능합니다.
마찬가지로, Masterflex 연동 펌프와 백금 경화 실리콘 튜빙은 탁월한 성능을 제공합니다. 찢어지거나 꼬이는 현상이 적으며, 매우 정밀한 공차로 제작되어 정확하고 반복 가능한 유량과 긴 수명을 보장합니다. 공장 출하 전 테스트 및 육안 검사를 거쳤습니다.
또한, 이 백금 경화 실리콘 튜빙은 과산화물 경화 튜빙보다 약간 더 투명합니다. 실제 성능은 튜빙 조성에 따라 달라지며, 실리콘은 배압이 10 PSIG(0.7 bar) 이하인 용도에만 권장됩니다.

바이오의약품 튜빙 시장 지역별 점유율
북미는 주요 업체들의 강력한 입지와 증가하는 의료 인프라 투자에 힘입어 시장 점유율의 40.5%를 차지하고 있습니다.

의료 분야의 기술 발전에 대한 수요가 증가함에 따라 북미 제조업체들은 사업 운영을 강화할 기회를 얻고 있습니다. 북미에는 많은 생산업체와 공급업체가 있으며, 이 지역의 빠른 경제 성장으로 산업 생산이 확대되어 제약 회사의 공정에 사용되는 바이오의약품 튜빙에 대한 수요가 증가하고 있습니다.
바이오의약품 튜빙을 지원하는 새로운 제품 출시 또한 시장 성장을 견인하고 있습니다. 예를 들어, 기술 기반 솔루션 및 소재 제공업체인 미국 듀폰은 2022년 7월 사우스캐롤라이나주 쿠퍼 리버에 새로 건설된 듀폰 리베오 헬스케어 생산 공장이 전 세계 고객에게 서비스를 제공하기 위해 가동을 시작할 것이라고 발표했습니다.
버클리 카운티에 위치한 이 시설은 듀폰의 유서 깊은 미시간주 헴록 바이오의약품 제조 시설인 듀폰 헬스케어 산업 소재 사이트와 동일한 높은 기준에 따라 운영될 것입니다.

2021년 10월, 듀폰은 고객 요구와 폭발적인 성장세를 반영하여 바이오의약품 공정 분야의 고객들을 위한 두 가지 새로운 핵심 제품 라인을 선보였습니다. 그중 하나는 Liveo Pharma의 TPE 튜빙으로, Liveo Silicone Pharma 튜빙과 동일한 고품질 및 고순도 기준에 따라 생산된 압출 열가소성 엘라스토머(TPE) 제약용 튜빙입니다. 이 제품은 유체 이송 및 일회용 바이오 공정 용도에 특화되어 설계되었습니다.

바이오의약품 튜빙 기업 및 경쟁 환경
바이오의약품 튜빙 시장의 주요 글로벌 기업으로는 W. L. Gore and Associates, Inc., Freudenberg Group (Freudenberg Medical), Rehu Group (RAUMEDIC AG), Genstar Capital (Tekni-Plex, Inc.), DuPont de Nemours, Inc., Holland Applied Technologies, Inc., Sartorius AG, Saint-Gobain, Ami Polymer, Nordson Corporation 등이 있습니다.

COVID-19가 바이오의약품 튜빙 시장에 미치는 영향
러시아-우크라이나 분쟁 분석
러시아는 우크라이나에 대한 불법적이고 도발 없는 전면 침공을 시작했으며, 이로 인해 미국, 유엔 및 기타 국가로부터 제재를 받았습니다. 현재의 위기 상황으로 인해 많은 기업들이 러시아에서의 사업 운영을 중단하기 시작했습니다. 이러한 제재는 기업들이 러시아 시장에서 철수함에 따라 세계 시장에 상당한 영향을 미칠 것입니다. 악화되는 재정적 제약으로 인해 러시아-우크라이나 분쟁은 러시아의 의료기기 산업에 악영향을 미칠 것입니다.
주요 동향
• 2022년 8월 9일, 듀폰은 중국 동부에 생산 시설을 추가하여 리베오 파마(Liveo Pharma) 실리콘 튜빙의 생산 능력을 확대할 것이라고 발표했습니다. 생산 시설 확장은 중화권에서 고성능, 고품질 바이오의약품 튜빙에 대한 수요를 충족하기 위한 것입니다.

• 2022년 8월 8일, 의료/제약 기기, 시스템, 부품 및 튜빙 제조업체인 프루덴베르크 메디컬(Freudenberg Medical)은 생물공정 및 일회용 유체 이송 용도에 사용되는 실리콘 소재의 오버몰딩 위생 마감재인 HelixTC를 출시했습니다. 프루덴베르크의 PharmaFocus Premium 제품 라인의 백금 경화 실리콘 튜빙이 HelixTC의 기반이 되며, 이는 기존의 바브형 TC 연결부를 대체하는 제품입니다.
• 2021년 10월 12일, 듀폰(DuPont)은 다가오는 전시회에서 새로운 듀폰 리베오 파마 TPE 튜빙을 선보였습니다. 유체 이송 및 일회용 생물공정 용도에 열가소성 엘라스토머(TPE) 기술을 활용한 압출 제약 튜빙 제품군의 추가는 리베오 실리콘 파마 튜빙 제품군과 동일한 고품질 및 고성능 기준을 준수한다는 점에서 브랜드에 중요한 전환점이 될 것입니다.
보고서를 구매해야 하는 이유?

• 유형, 적용 분야 및 지역별 글로벌 바이오의약품 튜빙 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 바이오의약품 튜빙 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 바이오의약품 튜빙 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

The Global Biopharmaceutical Tubing Market size reached USD 3,580.4 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,674.2 million by 2030. The biopharmaceutical tubing market is growing at a CAGR of 8.3% during the forecast period 2023-2030The medical and biopharmaceutical sectors' crucial needs are specifically met by biopharmaceutical tubing. Extrusion is used to create biopharmaceutical tubing, which is widely utilized in peristaltic pumps, feeding tubes and drug administration systems. Rising advantages of silicone tubing such as exceptional thermal, mechanical and chemical properties used in a wide range of applications, such as with anesthesiology and respiratory equipment, IVs and biopharmaceutical laboratory equipment will help in biopharmaceutical tubing market growth.
Biopharmaceutical Tubing Market Dynamics and Trends
The Growing Application of Single-use Systems (SUS) Drives the Growth of the Market.
The global biopharmaceutical tubing value is expanding as a result of the growing application of single-use systems (SUS). Due to their established dependability, cost-effectiveness and general system resilience, single-use systems are being used for production in both upstream and downstream operations by biopharmaceutical companies. Single-use system components are incorporated utilizing flexible biopharmaceutical tubing comprising sterile connections to process transfer lines and other equipment.
Biopharmaceutical manufacturers worldwide count on biopharmaceutical tubing for reliable, single-use, sterile connectors, sterile disconnects and open-format products that improve yield, cut costs and reduce time to market. Single-use connectors integrate manufacturing assemblies into upstream and downstream processes in a wide range of applications, including scale-up, sampling, chromatography, filtration and final fill.
Rising Government Funding and Advantages Provided by this Tubing Create Lucrative Growth Opportunities for Manufacturers.
Government and industry organizations have expended a great deal of effort to develop universal standardization for material integrity and purity for tubing and other components due to the fast rise of single-use systems (SUS) in the biopharmaceutical industry.
The capacity of silicone tubing to endure sterilization procedures, the delivery of positive extractable substance test results and the lack of substances produced from animals. These industries have tubing requirements that are common to several applications in terms of performance, flexibility and cost.
A peristaltic pump or silicone tubing is frequently used in the manufacturing operations of pharmaceutical companies. The specifications for high purity, flexible, peristaltic pump tubing which may be welded and sealed, hence omitting several materials, are met by tubing materials like TPE. Certain TPEs, like silicone, can be molded into connections like Ys and Ts, which further reduces the requirement for fittings and the risk of leakage.
Cyclosiloxanes Contaminates in Biopharmaceutical Tubing May Hamper the Market Growth.
Drug producers are getting more and more concerned about the potential sources of contamination from processing machinery. The FDA claimed that contamination from processing equipment was the cause of 15% of medicine recalls in the past six months, which gives you an idea of the scope of the issue.
A primary area of concern is the direct contact of plastic processing materials that comprise single-use components with the drug product. It is well recognized that this may lead to the presence of substances that could impact the final drug's effectiveness, safety or quality. The effects on product development or brand integrity are substantial for manufacturers engaged in multi-million dollar pharmacological studies and treatments.
Biopharmaceutical Tubing Market Segment Analysis
The global biopharmaceutical tubing market is segmented based on type, application and region.
Owing to the Rising Demand, the Silicone Biopharmaceutical Tubing Segment will Hold 53.8% of the Biopharmaceutical Tubing Market Share.
Pt-catalyzed silicone tubing is beneficial due to its inherent purity, pliability, and ease of sterilization. Also, silicone materials are inert and biocompatible, with no side effects. Silicone tubing is a great option for processing in the pharmaceutical and biopharma industries because of its robustness, kink resistance, as well as pressure resistance.
A thermoset polymer called silicone can endure temperatures as low as -80 °C and as high as 215 °C. This silicone class passes the USP 88 Class VI tests and is not sensitizing, pyrogenic, cytotoxic, genotoxic or hemolytic.
For instance, W. L. Gore and Associates, Inc., GORE STA-PURE Pump Tubing, Series PCS, utilizes an exceptional, patented hybrid design that overpowers silicon tubing limitations. Even at pressures up to 100 PSIG, Series PCS tubing provides uniform flow rates. Series PCS offers high flex durability and high resilience standard sizes and is compatible with CIP/SIP and autoclave sterilization.
Likewise, the Masterflex peristaltic pump and platinum-cured silicone tubing provide excellent performance. It is not prone to tear or kinking. It is made to extremely tight tolerances, ensuring accurate, repeatable flow and a long tubing life. It has been factory tested and inspected visually.
Also, this platinum-cured silicone tubing is slightly clearer than peroxide-cured tubing. Actual performance varies depending on tubing formulation; silicone is only recommended for applications with a back pressure of 10 PSIG (0.7 bar) or less.

Biopharmaceutical Tubing Market Geographical Penetration
North America Holds 40.5% of the Market Share Owing to the Strong Presence of Major Players and Increasing Healthcare Infrastructure Investment.
Due to the rising need for technological advancement in healthcare, North America, manufacturers have chances of enhancing their operations. There are many producers and suppliers in North America, and owing to the quick economic growth of the region, industrial production has been expanded, driving up the demand for biopharmaceutical tubing for processes in pharmaceutical companies.
Rising novel product launches to support biopharmaceutical tubing also drive market growth. For instance, in July 2022, DuPont, a technology-based solutions and materials provider company based in the U.S., announced that the newly constructed DuPont Liveo Healthcare production plant in Cooper River, South Carolina, would begin operations to serve clients throughout the world.
The Berkeley County facility will be run according to the same high standards as the company's venerable Hemlock, Michigan, biopharmaceutical manufacturing facility, the DuPont Healthcare Industries Materials Site.
In October 2021, to address customer demands and the healthcare sector's explosive growth, DuPont unveiled two new, significant product lines for its DuPont Liveo biopharmaceutical processing clients. TPE Tubing from Liveo Pharma - a variety of extruded thermoplastic elastomer (TPE) pharma tubing created using the same high-quality and high-purity standards as Liveo Silicone Pharma Tubing, specifically designed for fluid transfer and single-use bioprocessing applications.

Biopharmaceutical Tubing Companies and Competitive Landscape
The major global players in the biopharmaceutical tubing market include W. L. Gore and Associates, Inc., Freudenberg Group (Freudenberg Medical), Rehu Group (RAUMEDIC AG), Genstar Capital (Tekni-Plex, Inc.), DuPont de Nemours, Inc., Holland Applied Technologies, Inc., Sartorius AG, Saint-Gobain, Ami Polymer and Nordson Corporation among others.

COVID-19 Impact on Biopharmaceutical Tubing Market
Russia-Ukraine Conflict Analysis
Russia started its unlawful and unprovoked full-scale invasion of Ukraine, which resulted in sanctions against Russia from the US, the UN and other nations. In light of the current crisis, many businesses are starting to stop operating in Russia. These sanctions will surely have a significant effect on the worldwide market as businesses start to leave the Russian market. Due to worsening financial restrictions, the Russo-Ukrainian War will have a detrimental effect on the medical device industry in Russia.
Key Developments
• On August 9, 2022, DuPont declared that it would raise production capabilities for its Liveo Pharma Silicone Tubing by adding manufacturing capability in eastern China. Manufacturing expansion aims to meet the demand for high-performance, high-quality biopharmaceutical tubing in Greater China.
• On August 8, 2022, HelixTC over-molded sanitary ends in silicone have been introduced by Freudenberg Medical, a producer of medical or pharmaceutical devices, systems, elements, and tubing, for use in bioprocessing as well as single-use fluid transfer applications. The platinum-cured silicone tubing from Freudenberg's PharmaFocus Premium product line serves as the foundation for HelixTC, an alternative to conventional barbed TC connections.
• On October 12, 2021, DuPont launched new DuPont Liveo Pharma TPE tubing at upcoming trade shows. The addition of a line of extruded pharmaceutical tubing that utilizes thermoplastic elastomer (TPE) technology for fluid transportation and single-use bioprocessing applications marks an important turning point for the brand because it adheres to the same high-quality and high-performance standards as the Liveo Silicone Pharma Tubing range of products.
Why Purchase the Report?
• To visualize the global biopharmaceutical tubing- market segmentation based on type, application and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of biopharmaceutical tubing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Global Biopharmaceutical Tubing Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.
Target Audience 2023
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Application of Single-Use Systems (SUS)
4.1.1.2. Increasing Elderly Population
4.1.1.3. YY
4.1.2. Restraints
4.1.2.1. Cyclosiloxanes Contaminates In Biopharmaceutical Tubing
4.1.2.2. YY
4.1.3. Opportunity
4.1.3.1. YY
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Before COVID-19 Scenario
6.1.2. Present COVID-19 Scenario
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Silicone *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Plastic
7.4. Metal
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Pharmaceutical and Biopharmaceutical*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinical
8.4. Research and Development
8.5. Diagnosis
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. W. L. Gore and Associates, Inc. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. DuPont de Nemours, Inc.
11.3. Freudenberg Group (Freudenberg Medical)
11.4. REHAU Group (Raumedic AG)
11.5. Genstar Capital LLC (TekniPlex)
11.6. Holland Applied Technologies, Inc.
11.7. Sartorius AG
11.8. Saint-Gobain
11.9. Ami Polymer
11.10. Nordson Corporation (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

W. L. Gore and Associates, Inc., 4. Key Developments, DuPont de Nemours, Inc., Freudenberg Group (Freudenberg Medical), REHAU Group (Raumedic AG), Genstar Capital LLC (TekniPlex), Holland Applied Technologies, Inc., Sartorius AG, Saint-Gobain, Ami Polymer

표 목록 (Tables)

List of Tables Table 1 Global Biopharmaceutical Tubing Market Value, By Material, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Biopharmaceutical Tubing Market Value, By Usage, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Biopharmaceutical Tubing Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Biopharmaceutical Tubing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Biopharmaceutical Tubing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Biopharmaceutical Tubing Market Value, By Material, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Biopharmaceutical Tubing Market Value, By Material, 2022-2033 (US$ Billion)

Table 8 Global Biopharmaceutical Tubing Market Value, By Usage, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Biopharmaceutical Tubing Market Value, By Usage, 2022-2033 (US$ Billion)

Table 10 Global Biopharmaceutical Tubing Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Biopharmaceutical Tubing Market Value, By Application, 2022-2033 (US$ Billion)

Table 12 Global Biopharmaceutical Tubing Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Biopharmaceutical Tubing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 14 Global Biopharmaceutical Tubing Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Biopharmaceutical Tubing Market Value, By Region, 2022-2033 (US$ Billion)

Table 16 North America Biopharmaceutical Tubing Market Value, By Material, 2022-2033 (US$ Billion)

Table 17 North America Biopharmaceutical Tubing Market Value, By Usage, 2022-2033 (US$ Billion)

Table 18 North America Biopharmaceutical Tubing Market Value, By Application, 2022-2033 (US$ Billion)

Table 19 North America Biopharmaceutical Tubing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 North America Biopharmaceutical Tubing Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Biopharmaceutical Tubing Market Value, By Material, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Biopharmaceutical Tubing Market Value, By Usage, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Biopharmaceutical Tubing Market Value, By Application, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Biopharmaceutical Tubing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 25 Asia-Pacific Biopharmaceutical Tubing Market Value, By Country, 2022-2033 (US$ Billion)

Table 26 Europe Biopharmaceutical Tubing Market Value, By Material, 2022-2033 (US$ Billion)

Table 27 Europe Biopharmaceutical Tubing Market Value, By Usage, 2022-2033 (US$ Billion)

Table 28 Europe Biopharmaceutical Tubing Market Value, By Application, 2022-2033 (US$ Billion)

Table 29 Europe Biopharmaceutical Tubing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 30 Europe Biopharmaceutical Tubing Market Value, By Country, 2022-2033 (US$ Billion)

Table 31 South America Biopharmaceutical Tubing Market Value, By Material, 2022-2033 (US$ Billion)

Table 32 South America Biopharmaceutical Tubing Market Value, By Usage, 2022-2033 (US$ Billion)

Table 33 South America Biopharmaceutical Tubing Market Value, By Application, 2022-2033 (US$ Billion)

Table 34 South America Biopharmaceutical Tubing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 35 South America Biopharmaceutical Tubing Market Value, By Country, 2022-2033 (US$ Billion)

Table 36 Middle East and Africa Biopharmaceutical Tubing Market Value, By Material, 2022-2033 (US$ Billion)

Table 37 Middle East and Africa Biopharmaceutical Tubing Market Value, By Usage, 2022-2033 (US$ Billion)

Table 38 Middle East and Africa Biopharmaceutical Tubing Market Value, By Application, 2022-2033 (US$ Billion)

Table 39 Middle East and Africa Biopharmaceutical Tubing Market Value, By End-User, 2022-2033 (US$ Billion)

Table 40 Middle East and Africa Biopharmaceutical Tubing Market Value, By Country, 2022-2033 (US$ Billion)

Table 41 W. L. Gore & Associates, Inc.: Overview

Table 42 W. L. Gore & Associates, Inc.: Product Portfolio

Table 43 W. L. Gore & Associates, Inc.: Key Developments

Table 44 DuPont de Nemours, Inc.: Overview

Table 45 DuPont de Nemours, Inc.: Product Portfolio

Table 46 DuPont de Nemours, Inc.: Key Developments

Table 47 Holland Applied Technologies: Overview

Table 48 Holland Applied Technologies: Product Portfolio

Table 49 Holland Applied Technologies: Key Developments

Table 50 Saint-Gobain Life Sciences: Overview

Table 51 Saint-Gobain Life Sciences: Product Portfolio

Table 52 Saint-Gobain Life Sciences: Key Developments

Table 53 AdvantaPure: Overview

Table 54 AdvantaPure: Product Portfolio

Table 55 AdvantaPure: Key Developments

Table 56 Freudenberg Medical: Overview

Table 57 Freudenberg Medical: Product Portfolio

Table 58 Freudenberg Medical: Key Developments

Table 59 Kent Elastomer Products: Overview

Table 60 Kent Elastomer Products: Product Portfolio

Table 61 Kent Elastomer Products: Key Developments

Table 62 Fusion-Polymer: Overview

Table 63 Fusion-Polymer: Product Portfolio

Table 64 Fusion-Polymer: Key Developments

Table 65 Accuflow Systems: Overview

Table 66 Accuflow Systems: Product Portfolio

Table 67 Accuflow Systems: Key Developments

Table 68 Liquidyne Process Technologies, Inc.: Overview

Table 69 Liquidyne Process Technologies, Inc.: Product Portfolio

Table 70 Liquidyne Process Technologies, Inc.: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Biopharmaceutical Tubing Market Share, By Material, 2024 & 2033 (%)

Figure 3 Global Biopharmaceutical Tubing Market Share, By Usage, 2024 & 2033 (%)

Figure 4 Global Biopharmaceutical Tubing Market Share, By Application, 2024 & 2033 (%)

Figure 5 Global Biopharmaceutical Tubing Market Share, By End-User, 2024 & 2033 (%)

Figure 6 Global Biopharmaceutical Tubing Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Biopharmaceutical Tubing Market Y-o-Y Growth, By Material, 2023-2033 (%)

Figure 8 Silicone Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 9 TPE Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 10 Fluoropolymers (FEP, PTFE) Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 11 Polyethylene Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 12 PVC Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 13 Fluoroelastomers Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 14 Others Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 15 Global Biopharmaceutical Tubing Market Y-o-Y Growth, By Usage, 2023-2033 (%)

Figure 16 Single-use Usage in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 17 Multi-use Usage in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 18 Global Biopharmaceutical Tubing Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 19 Fluid Transfers in Bioprocess and Biomanufacturing Application in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 20 Single-use Assemblies Application in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 21 Peristaltic Pump Applications Application in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 22 Aseptic Connection and Disconnection Without Connectors Application in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 23 Others Application in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 24 Global Biopharmaceutical Tubing Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 25 Biotechnology Companies End-User in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 26 Pharmaceutical Companies End-User in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 27 Contract Development and Manufacturing Organizations (CDMOs) End-User in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 28 Research Laboratories End-User in Global Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 29 Global Biopharmaceutical Tubing Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 30 North America Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 31 North America Biopharmaceutical Tubing Market Share, By Material, 2024 & 2033 (%)

Figure 32 North America Biopharmaceutical Tubing Market Share, By Usage, 2024 & 2033 (%)

Figure 33 North America Biopharmaceutical Tubing Market Share, By Application, 2024 & 2033 (%)

Figure 34 North America Biopharmaceutical Tubing Market Share, By End-User, 2024 & 2033 (%)

Figure 35 North America Biopharmaceutical Tubing Market Share, By Country, 2024 & 2033 (%)

Figure 36 Asia-Pacific Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 37 Asia-Pacific Biopharmaceutical Tubing Market Share, By Material, 2024 & 2033 (%)

Figure 38 Asia-Pacific Biopharmaceutical Tubing Market Share, By Usage, 2024 & 2033 (%)

Figure 39 Asia-Pacific Biopharmaceutical Tubing Market Share, By Application, 2024 & 2033 (%)

Figure 40 Asia-Pacific Biopharmaceutical Tubing Market Share, By End-User, 2024 & 2033 (%)

Figure 41 Asia-Pacific Biopharmaceutical Tubing Market Share, By Country, 2024 & 2033 (%)

Figure 42 Europe Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 43 Europe Biopharmaceutical Tubing Market Share, By Material, 2024 & 2033 (%)

Figure 44 Europe Biopharmaceutical Tubing Market Share, By Usage, 2024 & 2033 (%)

Figure 45 Europe Biopharmaceutical Tubing Market Share, By Application, 2024 & 2033 (%)

Figure 46 Europe Biopharmaceutical Tubing Market Share, By End-User, 2024 & 2033 (%)

Figure 47 Europe Biopharmaceutical Tubing Market Share, By Country, 2024 & 2033 (%)

Figure 48 South America Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 49 South America Biopharmaceutical Tubing Market Share, By Material, 2024 & 2033 (%)

Figure 50 South America Biopharmaceutical Tubing Market Share, By Usage, 2024 & 2033 (%)

Figure 51 South America Biopharmaceutical Tubing Market Share, By Application, 2024 & 2033 (%)

Figure 52 South America Biopharmaceutical Tubing Market Share, By End-User, 2024 & 2033 (%)

Figure 53 South America Biopharmaceutical Tubing Market Share, By Country, 2024 & 2033 (%)

Figure 54 Middle East and Africa Biopharmaceutical Tubing Market Value, 2022-2033 (US$ Billion)

Figure 55 Middle East and Africa Biopharmaceutical Tubing Market Share, By Material, 2024 & 2033 (%)

Figure 56 Middle East and Africa Biopharmaceutical Tubing Market Share, By Usage, 2024 & 2033 (%)

Figure 57 Middle East and Africa Biopharmaceutical Tubing Market Share, By Application, 2024 & 2033 (%)

Figure 58 Middle East and Africa Biopharmaceutical Tubing Market Share, By End-User, 2024 & 2033 (%)

Figure 59 W. L. Gore & Associates, Inc.: Financials

Figure 60 DuPont de Nemours, Inc.: Financials

Figure 61 Holland Applied Technologies: Financials

Figure 62 Saint-Gobain Life Sciences: Financials

Figure 63 AdvantaPure: Financials

Figure 64 Freudenberg Medical: Financials

Figure 65 Kent Elastomer Products: Financials

Figure 66 Fusion-Polymer: Financials

Figure 67 Accuflow Systems: Financials

Figure 68 Liquidyne Process Technologies, Inc.: Financials